

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.44812728 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.44812728 |
| 3 | vascular endothelial growth factor signaling pathway (GO:0038084) | 5.31273974 |
| 4 | lymph vessel development (GO:0001945) | 4.95464240 |
| 5 | endothelium development (GO:0003158) | 4.78215504 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.62958301 |
| 7 | detection of other organism (GO:0098543) | 4.57990237 |
| 8 | blood vessel maturation (GO:0001955) | 4.49056121 |
| 9 | surfactant homeostasis (GO:0043129) | 4.47866463 |
| 10 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.43920986 |
| 11 | detection of molecule of bacterial origin (GO:0032490) | 4.38733031 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.31268140 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.28207256 |
| 14 | response to peptidoglycan (GO:0032494) | 4.21616761 |
| 15 | detection of bacterium (GO:0016045) | 4.21089661 |
| 16 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.11896564 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.11625365 |
| 18 | detection of external biotic stimulus (GO:0098581) | 4.10067538 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.06952283 |
| 20 | endothelial tube morphogenesis (GO:0061154) | 3.98976496 |
| 21 | morphogenesis of an endothelium (GO:0003159) | 3.98976496 |
| 22 | positive regulation of vasculogenesis (GO:2001214) | 3.89865409 |
| 23 | regulation of endothelial cell differentiation (GO:0045601) | 3.81838114 |
| 24 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.79692802 |
| 25 | lymphangiogenesis (GO:0001946) | 3.76146613 |
| 26 | detection of biotic stimulus (GO:0009595) | 3.66627484 |
| 27 | cardiac myofibril assembly (GO:0055003) | 3.65999113 |
| 28 | respiratory burst (GO:0045730) | 3.64317389 |
| 29 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.62908033 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 3.61464131 |
| 31 | neutrophil activation (GO:0042119) | 3.58525198 |
| 32 | regulation of vasculogenesis (GO:2001212) | 3.56304068 |
| 33 | leukocyte aggregation (GO:0070486) | 3.51399264 |
| 34 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.47291829 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46624870 |
| 36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46624870 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 3.46624870 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46624870 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.46624870 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46624870 |
| 41 | heart trabecula formation (GO:0060347) | 3.41153098 |
| 42 | basement membrane organization (GO:0071711) | 3.40158647 |
| 43 | response to muramyl dipeptide (GO:0032495) | 3.39660619 |
| 44 | negative regulation of granulocyte differentiation (GO:0030853) | 3.38942497 |
| 45 | substrate-dependent cell migration (GO:0006929) | 3.35035626 |
| 46 | macrophage activation (GO:0042116) | 3.34919312 |
| 47 | cellular extravasation (GO:0045123) | 3.34850023 |
| 48 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.34199695 |
| 49 | chemical homeostasis within a tissue (GO:0048875) | 3.30444794 |
| 50 | patterning of blood vessels (GO:0001569) | 3.30105325 |
| 51 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.29055910 |
| 52 | granulocyte activation (GO:0036230) | 3.26852505 |
| 53 | sarcomere organization (GO:0045214) | 3.24802074 |
| 54 | myofibril assembly (GO:0030239) | 3.22621962 |
| 55 | negative regulation of phagocytosis (GO:0050765) | 3.19474760 |
| 56 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.19233839 |
| 57 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.18641685 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.18481205 |
| 59 | neutrophil mediated immunity (GO:0002446) | 3.17187957 |
| 60 | blood vessel endothelial cell migration (GO:0043534) | 3.17099926 |
| 61 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.16787562 |
| 62 | venous blood vessel morphogenesis (GO:0048845) | 3.16653269 |
| 63 | regulation of gamma-delta T cell activation (GO:0046643) | 3.14083295 |
| 64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.10013056 |
| 65 | positive regulation of receptor recycling (GO:0001921) | 3.07877324 |
| 66 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.07318557 |
| 67 | endothelial cell morphogenesis (GO:0001886) | 3.06808599 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 3.06696297 |
| 69 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.03218465 |
| 70 | response to interleukin-15 (GO:0070672) | 3.02011437 |
| 71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.01647969 |
| 72 | glomerular filtration (GO:0003094) | 3.01376750 |
| 73 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.01079550 |
| 74 | coronary vasculature morphogenesis (GO:0060977) | 3.00654655 |
| 75 | regulation of leukocyte degranulation (GO:0043300) | 3.00054436 |
| 76 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.99086063 |
| 77 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.97059589 |
| 78 | renal filtration (GO:0097205) | 2.96170113 |
| 79 | protein localization to endosome (GO:0036010) | 2.94369781 |
| 80 | germinal center formation (GO:0002467) | 2.91302611 |
| 81 | ovulation from ovarian follicle (GO:0001542) | 2.91125593 |
| 82 | macrophage activation involved in immune response (GO:0002281) | 2.89949741 |
| 83 | plasma membrane repair (GO:0001778) | 2.86990560 |
| 84 | low-density lipoprotein particle clearance (GO:0034383) | 2.84848845 |
| 85 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.84150080 |
| 86 | myeloid cell activation involved in immune response (GO:0002275) | 2.83917636 |
| 87 | regulation of macrophage cytokine production (GO:0010935) | 2.83634820 |
| 88 | regulation of p38MAPK cascade (GO:1900744) | 2.82857943 |
| 89 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.82168514 |
| 90 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.79770653 |
| 91 | apoptotic cell clearance (GO:0043277) | 2.77652679 |
| 92 | vasculogenesis (GO:0001570) | 2.75250915 |
| 93 | response to fluid shear stress (GO:0034405) | 2.74301034 |
| 94 | regulation of cholesterol storage (GO:0010885) | 2.73883861 |
| 95 | positive regulation of p38MAPK cascade (GO:1900745) | 2.73532389 |
| 96 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.73232642 |
| 97 | positive regulation of histone deacetylation (GO:0031065) | 2.72511857 |
| 98 | negative regulation of type 2 immune response (GO:0002829) | 2.71906689 |
| 99 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.71649745 |
| 100 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.71511337 |
| 101 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.70973482 |
| 102 | regulation of T cell tolerance induction (GO:0002664) | 2.70373527 |
| 103 | endothelial cell differentiation (GO:0045446) | 2.69254813 |
| 104 | regulation of sequestering of triglyceride (GO:0010889) | 2.69034084 |
| 105 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.68868085 |
| 106 | fatty acid transmembrane transport (GO:1902001) | 2.68817038 |
| 107 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.68415688 |
| 108 | response to laminar fluid shear stress (GO:0034616) | 2.67572935 |
| 109 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.66621037 |
| 110 | myeloid leukocyte mediated immunity (GO:0002444) | 2.66079712 |
| 111 | hyaluronan catabolic process (GO:0030214) | 2.65557993 |
| 112 | cell adhesion mediated by integrin (GO:0033627) | 2.63185594 |
| 113 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.62577480 |
| 114 | negative regulation of stress fiber assembly (GO:0051497) | 2.61905572 |
| 115 | establishment of endothelial barrier (GO:0061028) | 2.61659505 |
| 116 | angiogenesis involved in wound healing (GO:0060055) | 2.61655783 |
| 117 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.61325221 |
| 118 | germ cell migration (GO:0008354) | 2.60766347 |
| 119 | regulation of tolerance induction (GO:0002643) | 2.60174309 |
| 120 | regulation of sarcomere organization (GO:0060297) | 2.60057327 |
| 121 | neutrophil chemotaxis (GO:0030593) | 2.57714265 |
| 122 | stress fiber assembly (GO:0043149) | 2.55504879 |
| 123 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.55177063 |
| 124 | regulation of regulated secretory pathway (GO:1903305) | 2.54533791 |
| 125 | sprouting angiogenesis (GO:0002040) | 2.52841470 |
| 126 | endothelial cell chemotaxis (GO:0035767) | 2.52659025 |
| 127 | microglial cell activation (GO:0001774) | 2.52356607 |
| 128 | neutrophil migration (GO:1990266) | 2.50264722 |
| 129 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.49396052 |
| 130 | positive regulation of mast cell activation (GO:0033005) | 2.49300222 |
| 131 | regulation of necroptotic process (GO:0060544) | 2.48732458 |
| 132 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.48535345 |
| 133 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.47792578 |
| 134 | endothelial cell migration (GO:0043542) | 2.47781986 |
| 135 | negative regulation of endothelial cell migration (GO:0010596) | 2.47525385 |
| 136 | negative regulation of glial cell proliferation (GO:0060253) | 2.47172946 |
| 137 | pinocytosis (GO:0006907) | 2.47079848 |
| 138 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.46998849 |
| 139 | negative regulation of T cell mediated immunity (GO:0002710) | 2.46760509 |
| 140 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.46507210 |
| 141 | response to host immune response (GO:0052572) | 2.46385458 |
| 142 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.46385458 |
| 143 | apoptotic process involved in morphogenesis (GO:0060561) | 2.46013884 |
| 144 | macrophage differentiation (GO:0030225) | 2.45936357 |
| 145 | cellular response to interleukin-15 (GO:0071350) | 2.45934896 |
| 146 | leukocyte degranulation (GO:0043299) | 2.45630280 |
| 147 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.45519853 |
| 148 | blood vessel remodeling (GO:0001974) | 2.45502944 |
| 149 | phospholipid homeostasis (GO:0055091) | 2.44649265 |
| 150 | negative regulation of heart growth (GO:0061117) | 2.43363755 |
| 151 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.43363755 |
| 152 | negative regulation of interleukin-6 production (GO:0032715) | 2.43343472 |
| 153 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.42803201 |
| 154 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.42705930 |
| 155 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.41508283 |
| 156 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.41104904 |
| 157 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.41090232 |
| 158 | negative regulation of platelet activation (GO:0010544) | 2.41076895 |
| 159 | semaphorin-plexin signaling pathway (GO:0071526) | 2.38693302 |
| 160 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.38636068 |
| 161 | response to host (GO:0075136) | 2.38636068 |
| 162 | response to host defenses (GO:0052200) | 2.38636068 |
| 163 | cardiac muscle hypertrophy (GO:0003300) | 2.35622924 |
| 164 | positive regulation of adherens junction organization (GO:1903393) | 2.34926242 |
| 165 | positive regulation of cell junction assembly (GO:1901890) | 2.33381749 |
| 166 | positive regulation of focal adhesion assembly (GO:0051894) | 2.33381749 |
| 167 | carnitine shuttle (GO:0006853) | 2.30978876 |
| 168 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.29173157 |
| 169 | cell-substrate junction assembly (GO:0007044) | 2.28626168 |
| 170 | positive regulation of lamellipodium assembly (GO:0010592) | 2.27261779 |
| 171 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.26992921 |
| 172 | actomyosin structure organization (GO:0031032) | 2.26823276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.32501945 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.12726905 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.38077849 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 2.84610229 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.76793802 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.66858874 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61365814 |
| 8 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.61222410 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.58950391 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.56833133 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.55073034 |
| 12 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.46073242 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46005515 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26672041 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.26021584 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.24537629 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.22404304 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.16897591 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.14109259 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.12534877 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10815655 |
| 22 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.03932576 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.01307116 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.01010686 |
| 25 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.99345419 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.92493498 |
| 27 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.91159786 |
| 28 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.91159786 |
| 29 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.88702106 |
| 30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.88000212 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86343405 |
| 32 | GATA1_19941826_ChIP-Seq_K562_Human | 1.85218089 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81008741 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80681821 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73607553 |
| 36 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.71646340 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68797823 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66946266 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.66798201 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.66617172 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66567097 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.66350752 |
| 43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.65002821 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.59521780 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.58655686 |
| 46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.56660174 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.56109872 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55690342 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.55450597 |
| 50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.54798229 |
| 51 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.54247150 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53559552 |
| 53 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.53260655 |
| 54 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.51227170 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.50908844 |
| 56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49746418 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49689231 |
| 58 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.47372302 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.47010890 |
| 60 | MYC_22102868_ChIP-Seq_BL_Human | 1.46808327 |
| 61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42875786 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42630757 |
| 63 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41284970 |
| 64 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.41187272 |
| 65 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40402547 |
| 66 | GATA2_19941826_ChIP-Seq_K562_Human | 1.39656990 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35233200 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.35112353 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34570465 |
| 70 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32350384 |
| 71 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29115019 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28340475 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28249669 |
| 74 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27076275 |
| 75 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27041585 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.27034439 |
| 77 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.24461720 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24332270 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24231806 |
| 80 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.24089500 |
| 81 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24037997 |
| 82 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.22476575 |
| 83 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.22476575 |
| 84 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.22476575 |
| 85 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.21968846 |
| 86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21439042 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21003708 |
| 88 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20930196 |
| 89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19587583 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18578557 |
| 91 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18546806 |
| 92 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18542678 |
| 93 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18124044 |
| 94 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17928231 |
| 95 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17868764 |
| 96 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17020479 |
| 97 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.16312029 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15354842 |
| 99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15261419 |
| 100 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14360276 |
| 101 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13317173 |
| 102 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.11249820 |
| 103 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.10319938 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10296695 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09913410 |
| 106 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09648415 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08863637 |
| 108 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08430260 |
| 109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08194656 |
| 110 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.07956704 |
| 111 | P68_20966046_ChIP-Seq_HELA_Human | 1.07000999 |
| 112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06743516 |
| 113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05621222 |
| 114 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.05118304 |
| 115 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04058706 |
| 116 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03607647 |
| 117 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02462325 |
| 118 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.02018671 |
| 119 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01949642 |
| 120 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.01351110 |
| 121 | * MYB_26560356_Chip-Seq_TH1_Human | 1.00492688 |
| 122 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00479183 |
| 123 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00359467 |
| 124 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00300065 |
| 125 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99066812 |
| 126 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98435092 |
| 127 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98073314 |
| 128 | MYB_26560356_Chip-Seq_TH2_Human | 0.97981910 |
| 129 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95202442 |
| 130 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93975078 |
| 131 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92960108 |
| 132 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.92500702 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 5.14735409 |
| 2 | MP0005167_abnormal_blood-brain_barrier | 3.78506020 |
| 3 | MP0001879_abnormal_lymphatic_vessel | 3.71585910 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.35813154 |
| 5 | MP0003828_pulmonary_edema | 2.92616128 |
| 6 | MP0008260_abnormal_autophagy | 2.66290623 |
| 7 | MP0003303_peritoneal_inflammation | 2.65982473 |
| 8 | MP0004272_abnormal_basement_membrane | 2.55199525 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.49901458 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.41648316 |
| 11 | MP0009278_abnormal_bone_marrow | 2.32835204 |
| 12 | MP0003724_increased_susceptibility_to | 2.31004585 |
| 13 | MP0000343_altered_response_to | 2.22255233 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.16220297 |
| 15 | MP0004858_abnormal_nervous_system | 2.10445718 |
| 16 | MP0004036_abnormal_muscle_relaxation | 2.02374367 |
| 17 | MP0004215_abnormal_myocardial_fiber | 2.01554618 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.01148817 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.00747794 |
| 20 | MP0003279_aneurysm | 1.96871396 |
| 21 | MP0005451_abnormal_body_composition | 1.90779046 |
| 22 | MP0001849_ear_inflammation | 1.89040755 |
| 23 | MP0005409_darkened_coat_color | 1.78358584 |
| 24 | MP0006138_congestive_heart_failure | 1.76775112 |
| 25 | MP0000767_abnormal_smooth_muscle | 1.75881459 |
| 26 | MP0010630_abnormal_cardiac_muscle | 1.75570144 |
| 27 | MP0004510_myositis | 1.75543613 |
| 28 | MP0004130_abnormal_muscle_cell | 1.73390432 |
| 29 | MP0005330_cardiomyopathy | 1.70112141 |
| 30 | MP0001544_abnormal_cardiovascular_syste | 1.67888923 |
| 31 | MP0005385_cardiovascular_system_phenoty | 1.67888923 |
| 32 | MP0001790_abnormal_immune_system | 1.64167238 |
| 33 | MP0005387_immune_system_phenotype | 1.64167238 |
| 34 | MP0008775_abnormal_heart_ventricle | 1.64035837 |
| 35 | MP0000751_myopathy | 1.63992231 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.63190489 |
| 37 | MP0001819_abnormal_immune_cell | 1.62911129 |
| 38 | MP0005670_abnormal_white_adipose | 1.62581599 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.60478817 |
| 40 | MP0002972_abnormal_cardiac_muscle | 1.55862002 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.54849240 |
| 42 | MP0002723_abnormal_immune_serum | 1.54412672 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.53692405 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.53692405 |
| 45 | MP0000685_abnormal_immune_system | 1.53488165 |
| 46 | MP0000858_altered_metastatic_potential | 1.52634380 |
| 47 | MP0001958_emphysema | 1.51316868 |
| 48 | MP0001800_abnormal_humoral_immune | 1.50582696 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.48516123 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.48265079 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.45805399 |
| 52 | MP0004947_skin_inflammation | 1.44318366 |
| 53 | MP0004381_abnormal_hair_follicle | 1.43133043 |
| 54 | MP0000249_abnormal_blood_vessel | 1.42669498 |
| 55 | MP0002132_abnormal_respiratory_system | 1.41719724 |
| 56 | MP0006054_spinal_hemorrhage | 1.41409586 |
| 57 | MP0009840_abnormal_foam_cell | 1.40498887 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.38906085 |
| 59 | MP0004087_abnormal_muscle_fiber | 1.36867096 |
| 60 | MP0004484_altered_response_of | 1.32867734 |
| 61 | MP0005165_increased_susceptibility_to | 1.32044669 |
| 62 | MP0003436_decreased_susceptibility_to | 1.25824184 |
| 63 | MP0000749_muscle_degeneration | 1.25673331 |
| 64 | MP0002419_abnormal_innate_immunity | 1.24377782 |
| 65 | MP0002128_abnormal_blood_circulation | 1.24314317 |
| 66 | MP0005076_abnormal_cell_differentiation | 1.24056239 |
| 67 | MP0002396_abnormal_hematopoietic_system | 1.22989848 |
| 68 | MP0001851_eye_inflammation | 1.22946149 |
| 69 | MP0005666_abnormal_adipose_tissue | 1.22552949 |
| 70 | MP0000750_abnormal_muscle_regeneration | 1.22075751 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 1.18842409 |
| 72 | MP0004808_abnormal_hematopoietic_stem | 1.18276157 |
| 73 | MP0002925_abnormal_cardiovascular_devel | 1.16847557 |
| 74 | MP0005671_abnormal_response_to | 1.16685406 |
| 75 | MP0005390_skeleton_phenotype | 1.16050254 |
| 76 | MP0002398_abnormal_bone_marrow | 1.15720772 |
| 77 | MP0002933_joint_inflammation | 1.15378135 |
| 78 | MP0002332_abnormal_exercise_endurance | 1.13254634 |
| 79 | MP0000716_abnormal_immune_system | 1.12388438 |
| 80 | MP0008004_abnormal_stomach_pH | 1.09950966 |
| 81 | MP0003075_altered_response_to | 1.09457826 |
| 82 | MP0004883_abnormal_blood_vessel | 1.08750695 |
| 83 | MP0002148_abnormal_hypersensitivity_rea | 1.08202915 |
| 84 | MP0001614_abnormal_blood_vessel | 1.08061862 |
| 85 | MP0004085_abnormal_heartbeat | 1.07926344 |
| 86 | MP0000266_abnormal_heart_morphology | 1.06903545 |
| 87 | MP0005620_abnormal_muscle_contractility | 1.06723380 |
| 88 | MP0010155_abnormal_intestine_physiology | 1.05867096 |
| 89 | MP0001915_intracranial_hemorrhage | 1.02830241 |
| 90 | MP0001533_abnormal_skeleton_physiology | 1.02799102 |
| 91 | MP0002166_altered_tumor_susceptibility | 1.02550042 |
| 92 | MP0002877_abnormal_melanocyte_morpholog | 1.00137199 |
| 93 | MP0000678_abnormal_parathyroid_gland | 0.98845023 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.98688810 |
| 95 | MP0003646_muscle_fatigue | 0.97721111 |
| 96 | MP0002429_abnormal_blood_cell | 0.95751887 |
| 97 | MP0008438_abnormal_cutaneous_collagen | 0.95650601 |
| 98 | MP0002722_abnormal_immune_system | 0.95411695 |
| 99 | MP0001853_heart_inflammation | 0.94836568 |
| 100 | MP0002133_abnormal_respiratory_system | 0.94478536 |
| 101 | MP0005388_respiratory_system_phenotype | 0.94478536 |
| 102 | MP0005023_abnormal_wound_healing | 0.93932747 |
| 103 | MP0002254_reproductive_system_inflammat | 0.92529855 |
| 104 | MP0004233_abnormal_muscle_weight | 0.92450075 |
| 105 | MP0000703_abnormal_thymus_morphology | 0.92169125 |
| 106 | MP0004147_increased_porphyrin_level | 0.91957421 |
| 107 | MP0005595_abnormal_vascular_smooth | 0.91731572 |
| 108 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91033516 |
| 109 | MP0003690_abnormal_glial_cell | 0.89977646 |
| 110 | MP0006082_CNS_inflammation | 0.89876692 |
| 111 | MP0003091_abnormal_cell_migration | 0.89600148 |
| 112 | MP0005164_abnormal_response_to | 0.88443728 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.88422572 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.87286039 |
| 115 | MP0005025_abnormal_response_to | 0.86868499 |
| 116 | MP0005360_urolithiasis | 0.86329464 |
| 117 | MP0003950_abnormal_plasma_membrane | 0.85955541 |
| 118 | MP0003252_abnormal_bile_duct | 0.85612134 |
| 119 | MP0003763_abnormal_thymus_physiology | 0.84768791 |
| 120 | MP0002106_abnormal_muscle_physiology | 0.84728523 |
| 121 | MP0008469_abnormal_protein_level | 0.84348938 |
| 122 | MP0009785_altered_susceptibility_to | 0.83666273 |
| 123 | MP0005377_hearing/vestibular/ear_phenot | 0.83542660 |
| 124 | MP0003878_abnormal_ear_physiology | 0.83542660 |
| 125 | MP0010329_abnormal_lipoprotein_level | 0.82414599 |
| 126 | MP0004782_abnormal_surfactant_physiolog | 0.81425545 |
| 127 | MP0000689_abnormal_spleen_morphology | 0.80620458 |
| 128 | MP0001835_abnormal_antigen_presentation | 0.80296656 |
| 129 | MP0002127_abnormal_cardiovascular_syste | 0.80071442 |
| 130 | MP0009053_abnormal_anal_canal | 0.79601054 |
| 131 | MP0009333_abnormal_splenocyte_physiolog | 0.79250896 |
| 132 | MP0005248_abnormal_Harderian_gland | 0.78844997 |
| 133 | MP0009764_decreased_sensitivity_to | 0.78273389 |
| 134 | MP0008961_abnormal_basal_metabolism | 0.77749198 |
| 135 | MP0000609_abnormal_liver_physiology | 0.75947627 |
| 136 | MP0005319_abnormal_enzyme/_coenzyme | 0.74368341 |
| 137 | MP0005166_decreased_susceptibility_to | 0.72741102 |
| 138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72581769 |
| 139 | MP0002452_abnormal_antigen_presenting | 0.70829399 |
| 140 | MP0000230_abnormal_systemic_arterial | 0.68490145 |
| 141 | MP0003448_altered_tumor_morphology | 0.68398028 |
| 142 | MP0002405_respiratory_system_inflammati | 0.68202644 |
| 143 | MP0002269_muscular_atrophy | 0.68167343 |
| 144 | MP0003045_fibrosis | 0.67930141 |
| 145 | MP0001845_abnormal_inflammatory_respons | 0.67879222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hematochezia (HP:0002573) | 5.43850672 |
| 2 | Polycythemia (HP:0001901) | 5.05715078 |
| 3 | Spontaneous hematomas (HP:0007420) | 4.79813186 |
| 4 | Cerebral aneurysm (HP:0004944) | 4.50548394 |
| 5 | Myositis (HP:0100614) | 4.38148375 |
| 6 | Orchitis (HP:0100796) | 4.17390160 |
| 7 | Ventricular tachycardia (HP:0004756) | 3.94115575 |
| 8 | Sudden death (HP:0001699) | 3.71871619 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.67655889 |
| 10 | Optic neuritis (HP:0100653) | 3.48334540 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 3.48334540 |
| 12 | Esophageal varix (HP:0002040) | 3.38742593 |
| 13 | Muscle fiber splitting (HP:0003555) | 3.35860124 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.28746533 |
| 15 | Peritonitis (HP:0002586) | 3.22911624 |
| 16 | Obstructive lung disease (HP:0006536) | 3.19093171 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19093171 |
| 18 | Lymphangioma (HP:0100764) | 3.13078578 |
| 19 | Gingivitis (HP:0000230) | 3.13050365 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.09749195 |
| 21 | Recurrent abscess formation (HP:0002722) | 3.05613182 |
| 22 | Asymmetric septal hypertrophy (HP:0001670) | 3.03118202 |
| 23 | Atrial fibrillation (HP:0005110) | 3.01400436 |
| 24 | Increased connective tissue (HP:0009025) | 2.99804536 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 2.97238499 |
| 26 | Abnormality of the nasal mucosa (HP:0000433) | 2.97228594 |
| 27 | Hyporeflexia of lower limbs (HP:0002600) | 2.96667089 |
| 28 | Cellulitis (HP:0100658) | 2.92275593 |
| 29 | Complement deficiency (HP:0004431) | 2.90538207 |
| 30 | Glomerulonephritis (HP:0000099) | 2.90394262 |
| 31 | Lipoatrophy (HP:0100578) | 2.84736247 |
| 32 | Aortic aneurysm (HP:0004942) | 2.84042712 |
| 33 | Supraventricular arrhythmia (HP:0005115) | 2.81691126 |
| 34 | Primary atrial arrhythmia (HP:0001692) | 2.79515770 |
| 35 | Increased IgE level (HP:0003212) | 2.79306501 |
| 36 | Metaphyseal cupping (HP:0003021) | 2.76326392 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.75772789 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.75477559 |
| 39 | Abnormal vertebral ossification (HP:0100569) | 2.73304178 |
| 40 | Deep venous thrombosis (HP:0002625) | 2.72786928 |
| 41 | Keratoconjunctivitis sicca (HP:0001097) | 2.72767331 |
| 42 | Stomatitis (HP:0010280) | 2.71647785 |
| 43 | Hypochromic microcytic anemia (HP:0004840) | 2.68388623 |
| 44 | Supraventricular tachycardia (HP:0004755) | 2.66314571 |
| 45 | Protrusio acetabuli (HP:0003179) | 2.64128674 |
| 46 | Abnormal platelet function (HP:0011869) | 2.63360334 |
| 47 | Impaired platelet aggregation (HP:0003540) | 2.63360334 |
| 48 | Subaortic stenosis (HP:0001682) | 2.62779365 |
| 49 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.62779365 |
| 50 | Visceral angiomatosis (HP:0100761) | 2.62550826 |
| 51 | Conjunctival telangiectasia (HP:0000524) | 2.61691263 |
| 52 | Chest pain (HP:0100749) | 2.59793459 |
| 53 | Aneurysm (HP:0002617) | 2.59776892 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 2.55369330 |
| 55 | Broad metatarsal (HP:0001783) | 2.53748205 |
| 56 | Exercise-induced muscle cramps (HP:0003710) | 2.52769788 |
| 57 | Hemangiomatosis (HP:0007461) | 2.52416281 |
| 58 | Right ventricular cardiomyopathy (HP:0011663) | 2.50547786 |
| 59 | Cerebral hemorrhage (HP:0001342) | 2.48296274 |
| 60 | Difficulty running (HP:0009046) | 2.47994936 |
| 61 | Disproportionate tall stature (HP:0001519) | 2.47874866 |
| 62 | Obstructive sleep apnea (HP:0002870) | 2.45065119 |
| 63 | Increased variability in muscle fiber diameter (HP:0003557) | 2.45053874 |
| 64 | Axonal loss (HP:0003447) | 2.43224163 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.42418613 |
| 66 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.41963669 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.41252334 |
| 68 | Nonimmune hydrops fetalis (HP:0001790) | 2.40807207 |
| 69 | Nephritis (HP:0000123) | 2.38984704 |
| 70 | Recurrent fungal infections (HP:0002841) | 2.38661683 |
| 71 | Keratoconjunctivitis (HP:0001096) | 2.36826270 |
| 72 | Hemorrhage of the eye (HP:0011885) | 2.34612720 |
| 73 | Urticaria (HP:0001025) | 2.31810665 |
| 74 | Recurrent skin infections (HP:0001581) | 2.30611449 |
| 75 | Atrioventricular block (HP:0001678) | 2.30603314 |
| 76 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.30407177 |
| 77 | Arterial tortuosity (HP:0005116) | 2.27959874 |
| 78 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.25807160 |
| 79 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.25069623 |
| 80 | Meningitis (HP:0001287) | 2.24843301 |
| 81 | Mucosal telangiectasiae (HP:0100579) | 2.24416445 |
| 82 | Dilated cardiomyopathy (HP:0001644) | 2.23686858 |
| 83 | Hemoptysis (HP:0002105) | 2.23528286 |
| 84 | Pulmonary artery stenosis (HP:0004415) | 2.19559121 |
| 85 | Dilatation of the ascending aorta (HP:0005111) | 2.17378417 |
| 86 | Mitral valve prolapse (HP:0001634) | 2.17331278 |
| 87 | Bicuspid aortic valve (HP:0001647) | 2.15979532 |
| 88 | Broad face (HP:0000283) | 2.15543715 |
| 89 | Abnormality of the peritoneum (HP:0002585) | 2.14473452 |
| 90 | Hypochromic anemia (HP:0001931) | 2.14444364 |
| 91 | Striae distensae (HP:0001065) | 2.12255828 |
| 92 | Cavernous hemangioma (HP:0001048) | 2.12066295 |
| 93 | Abnormality of complement system (HP:0005339) | 2.11775649 |
| 94 | Myoglobinuria (HP:0002913) | 2.11506937 |
| 95 | Arterial thrombosis (HP:0004420) | 2.11134299 |
| 96 | Increased cerebral lipofuscin (HP:0011813) | 2.09601221 |
| 97 | Syncope (HP:0001279) | 2.09390664 |
| 98 | Episodic fever (HP:0001954) | 2.07835795 |
| 99 | Vascular tortuosity (HP:0004948) | 2.07662154 |
| 100 | EMG: myopathic abnormalities (HP:0003458) | 2.06680320 |
| 101 | Calf muscle hypertrophy (HP:0008981) | 2.06536527 |
| 102 | Neonatal death (HP:0003811) | 2.05400448 |
| 103 | Subacute progressive viral hepatitis (HP:0006572) | 2.05123665 |
| 104 | Bone cyst (HP:0012062) | 2.03755698 |
| 105 | Encephalitis (HP:0002383) | 2.01538026 |
| 106 | Cervical subluxation (HP:0003308) | 2.00541901 |
| 107 | Shallow orbits (HP:0000586) | 2.00448686 |
| 108 | Exercise-induced myalgia (HP:0003738) | 1.99841865 |
| 109 | Colitis (HP:0002583) | 1.99567070 |
| 110 | Polygenic inheritance (HP:0010982) | 1.99487181 |
| 111 | Epistaxis (HP:0000421) | 1.97980671 |
| 112 | Pulmonary embolism (HP:0002204) | 1.97414759 |
| 113 | Tetraparesis (HP:0002273) | 1.94851197 |
| 114 | Heart block (HP:0012722) | 1.94081332 |
| 115 | Abnormality of macrophages (HP:0004311) | 1.93636040 |
| 116 | Myocardial infarction (HP:0001658) | 1.93162881 |
| 117 | Urethral obstruction (HP:0000796) | 1.93119209 |
| 118 | Joint hemorrhage (HP:0005261) | 1.92999230 |
| 119 | Aortic dissection (HP:0002647) | 1.92961855 |
| 120 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.92458305 |
| 121 | Facial diplegia (HP:0001349) | 1.91560074 |
| 122 | Premature loss of primary teeth (HP:0006323) | 1.91491240 |
| 123 | Premature rupture of membranes (HP:0001788) | 1.90419145 |
| 124 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.89892785 |
| 125 | Vasculitis (HP:0002633) | 1.89830280 |
| 126 | Microcytic anemia (HP:0001935) | 1.89692961 |
| 127 | Hemiplegia (HP:0002301) | 1.87680075 |
| 128 | Mesangial abnormality (HP:0001966) | 1.86408291 |
| 129 | Skull defect (HP:0001362) | 1.80313362 |
| 130 | Abnormal atrioventricular conduction (HP:0005150) | 1.79828124 |
| 131 | Stroke (HP:0001297) | 1.78127700 |
| 132 | Long toe (HP:0010511) | 1.76576753 |
| 133 | Difficulty climbing stairs (HP:0003551) | 1.76481900 |
| 134 | Menorrhagia (HP:0000132) | 1.76288774 |
| 135 | Rhabdomyolysis (HP:0003201) | 1.76236699 |
| 136 | Blue sclerae (HP:0000592) | 1.76213959 |
| 137 | Abnormal platelet volume (HP:0011876) | 1.75641410 |
| 138 | Abnormality of the endocardium (HP:0004306) | 1.75033968 |
| 139 | Osteomyelitis (HP:0002754) | 1.74811436 |
| 140 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.74453790 |
| 141 | Portal hypertension (HP:0001409) | 1.74421064 |
| 142 | Recurrent cutaneous fungal infections (HP:0011370) | 1.73618157 |
| 143 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.73618157 |
| 144 | Cardiomegaly (HP:0001640) | 1.73354393 |
| 145 | Increased mean platelet volume (HP:0011877) | 1.73051915 |
| 146 | Sepsis (HP:0100806) | 1.72935929 |
| 147 | Thoracic kyphosis (HP:0002942) | 1.72387038 |
| 148 | Abnormality of the calf musculature (HP:0001430) | 1.72284135 |
| 149 | Onion bulb formation (HP:0003383) | 1.71953386 |
| 150 | Gastrointestinal inflammation (HP:0004386) | 1.71949783 |
| 151 | Palpitations (HP:0001962) | 1.71715992 |
| 152 | Bundle branch block (HP:0011710) | 1.71483209 |
| 153 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.71476266 |
| 154 | Hypoglycemic coma (HP:0001325) | 1.71367958 |
| 155 | Hepatosplenomegaly (HP:0001433) | 1.71198110 |
| 156 | Distal lower limb muscle weakness (HP:0009053) | 1.70708995 |
| 157 | Prolonged QT interval (HP:0001657) | 1.70688954 |
| 158 | Amyloidosis (HP:0011034) | 1.70678241 |
| 159 | Distal lower limb amyotrophy (HP:0008944) | 1.68222183 |
| 160 | Anorexia (HP:0002039) | 1.66640398 |
| 161 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.64692365 |
| 162 | Short 4th metacarpal (HP:0010044) | 1.64692365 |
| 163 | Gingival bleeding (HP:0000225) | 1.64649812 |
| 164 | Hypertriglyceridemia (HP:0002155) | 1.64206465 |
| 165 | Inflammation of the large intestine (HP:0002037) | 1.63312833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 7.58720704 |
| 2 | TGFBR2 | 4.99739497 |
| 3 | KDR | 4.82339209 |
| 4 | RIPK4 | 3.39721085 |
| 5 | TTN | 2.85593742 |
| 6 | TRIB3 | 2.73105944 |
| 7 | PKN2 | 2.59380896 |
| 8 | ERN1 | 2.22167670 |
| 9 | RIPK1 | 2.16377091 |
| 10 | MAP2K3 | 2.04930322 |
| 11 | EPHB1 | 1.94921350 |
| 12 | TAOK1 | 1.93248551 |
| 13 | CAMK1D | 1.88126961 |
| 14 | SMG1 | 1.86569657 |
| 15 | PTK6 | 1.86549867 |
| 16 | TNK2 | 1.82556689 |
| 17 | PAK4 | 1.78891596 |
| 18 | TGFBR1 | 1.78169859 |
| 19 | PRPF4B | 1.77383246 |
| 20 | MARK2 | 1.74501481 |
| 21 | FGR | 1.60554940 |
| 22 | DMPK | 1.59285752 |
| 23 | CAMK1G | 1.58155365 |
| 24 | PTK2B | 1.46107531 |
| 25 | PRKD2 | 1.45846854 |
| 26 | MAP4K1 | 1.42556748 |
| 27 | KSR2 | 1.41570591 |
| 28 | TYK2 | 1.33258434 |
| 29 | MAP3K6 | 1.30283170 |
| 30 | STK10 | 1.29276489 |
| 31 | MYLK | 1.28654876 |
| 32 | MAP3K13 | 1.24545032 |
| 33 | KIT | 1.21341510 |
| 34 | YES1 | 1.21182554 |
| 35 | GRK6 | 1.13663168 |
| 36 | TBK1 | 1.10028240 |
| 37 | LRRK2 | 1.09835914 |
| 38 | MAP3K3 | 1.08785632 |
| 39 | CSK | 1.08323097 |
| 40 | CSF1R | 1.08117176 |
| 41 | FES | 1.05334289 |
| 42 | ZAP70 | 1.01608190 |
| 43 | JAK1 | 1.00114105 |
| 44 | CDC42BPA | 0.99224776 |
| 45 | PRKG2 | 0.98393052 |
| 46 | MAPK12 | 0.97177455 |
| 47 | MAPK15 | 0.95981420 |
| 48 | SIK3 | 0.93344301 |
| 49 | EPHB2 | 0.90653640 |
| 50 | MAP3K10 | 0.89795918 |
| 51 | TEC | 0.88780606 |
| 52 | GRK7 | 0.87900810 |
| 53 | FGFR4 | 0.86935945 |
| 54 | PRKD1 | 0.86541694 |
| 55 | PDGFRA | 0.86186592 |
| 56 | PRKAA2 | 0.83383208 |
| 57 | IRAK2 | 0.83168539 |
| 58 | BMX | 0.82353687 |
| 59 | HCK | 0.81197100 |
| 60 | EEF2K | 0.79720887 |
| 61 | RPS6KA2 | 0.79634718 |
| 62 | ITK | 0.78043172 |
| 63 | IRAK4 | 0.77118511 |
| 64 | IRAK3 | 0.74584859 |
| 65 | JAK2 | 0.73077363 |
| 66 | TRPM7 | 0.72793512 |
| 67 | MAP3K14 | 0.72022065 |
| 68 | LYN | 0.69355969 |
| 69 | IRAK1 | 0.69178186 |
| 70 | BTK | 0.68683592 |
| 71 | SIK1 | 0.68025044 |
| 72 | CDK19 | 0.67571865 |
| 73 | FGFR3 | 0.67538252 |
| 74 | PTK2 | 0.67049937 |
| 75 | STK38 | 0.66028615 |
| 76 | LMTK2 | 0.66017188 |
| 77 | MAPK7 | 0.65763592 |
| 78 | CLK1 | 0.65349667 |
| 79 | NEK9 | 0.64994205 |
| 80 | SIK2 | 0.64782009 |
| 81 | MAP3K7 | 0.64512688 |
| 82 | FLT3 | 0.64397172 |
| 83 | CAMK4 | 0.64210425 |
| 84 | MAPKAPK3 | 0.63530768 |
| 85 | NTRK1 | 0.61853782 |
| 86 | MAP3K11 | 0.61219782 |
| 87 | GRK1 | 0.60903834 |
| 88 | BCKDK | 0.60714896 |
| 89 | TAOK2 | 0.59046234 |
| 90 | MAP3K8 | 0.58939030 |
| 91 | DYRK1B | 0.58787414 |
| 92 | PDPK1 | 0.58538823 |
| 93 | STK11 | 0.58356527 |
| 94 | MARK3 | 0.58012564 |
| 95 | PDK2 | 0.57060678 |
| 96 | SGK3 | 0.56592504 |
| 97 | OBSCN | 0.55910827 |
| 98 | CDK6 | 0.55105010 |
| 99 | FYN | 0.54372672 |
| 100 | JAK3 | 0.54328003 |
| 101 | SYK | 0.52589815 |
| 102 | PDGFRB | 0.50538919 |
| 103 | MOS | 0.49942438 |
| 104 | PAK2 | 0.49519983 |
| 105 | EGFR | 0.48620238 |
| 106 | TAOK3 | 0.48450766 |
| 107 | MAP2K4 | 0.48415224 |
| 108 | ILK | 0.47823946 |
| 109 | PRKCH | 0.47504191 |
| 110 | ICK | 0.47134239 |
| 111 | KSR1 | 0.46255627 |
| 112 | MATK | 0.46045020 |
| 113 | MAP3K2 | 0.45349672 |
| 114 | INSRR | 0.43472534 |
| 115 | CDK12 | 0.43070358 |
| 116 | MTOR | 0.42581943 |
| 117 | GSK3A | 0.41640794 |
| 118 | PHKG1 | 0.41537773 |
| 119 | PHKG2 | 0.41537773 |
| 120 | TESK2 | 0.41310784 |
| 121 | IKBKE | 0.40225950 |
| 122 | HIPK2 | 0.39679791 |
| 123 | STK24 | 0.38744519 |
| 124 | TYRO3 | 0.38501908 |
| 125 | LCK | 0.37580789 |
| 126 | STK4 | 0.37342211 |
| 127 | FGFR2 | 0.36530890 |
| 128 | IGF1R | 0.35823916 |
| 129 | PDK1 | 0.35669435 |
| 130 | RET | 0.34820095 |
| 131 | MAPK4 | 0.33473363 |
| 132 | MAP3K1 | 0.33370747 |
| 133 | FER | 0.32796969 |
| 134 | RPS6KC1 | 0.32557338 |
| 135 | RPS6KL1 | 0.32557338 |
| 136 | PRKAA1 | 0.32227389 |
| 137 | RPS6KA6 | 0.32206261 |
| 138 | STK3 | 0.30597232 |
| 139 | BLK | 0.29448411 |
| 140 | MAPKAPK2 | 0.28258314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.72035338 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.04917921 |
| 3 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.03898510 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.95561777 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.91793055 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.89045403 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.81556700 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.81121433 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.81050355 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.77694235 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.73547593 |
| 12 | Focal adhesion_Homo sapiens_hsa04510 | 1.70389921 |
| 13 | Platelet activation_Homo sapiens_hsa04611 | 1.62168150 |
| 14 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.59466921 |
| 15 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.59233121 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.57915726 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53844501 |
| 18 | Insulin resistance_Homo sapiens_hsa04931 | 1.45959973 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.44582998 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.43875569 |
| 21 | Adherens junction_Homo sapiens_hsa04520 | 1.39691853 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39469146 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36635909 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.35868084 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32470165 |
| 26 | Amoebiasis_Homo sapiens_hsa05146 | 1.31445780 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.31187522 |
| 28 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.31114055 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.31055494 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28954606 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28840248 |
| 32 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.26667159 |
| 33 | Lysine degradation_Homo sapiens_hsa00310 | 1.23882881 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17529854 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.16988390 |
| 36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.13573391 |
| 37 | Endometrial cancer_Homo sapiens_hsa05213 | 1.11825046 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.11339980 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.11319749 |
| 40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11199008 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10489046 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10432935 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.10149981 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10139011 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10109400 |
| 46 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.09151374 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09073253 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08293806 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04632266 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.02187749 |
| 51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.01172946 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00951782 |
| 53 | Bladder cancer_Homo sapiens_hsa05219 | 1.00895492 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98362556 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98327970 |
| 56 | Colorectal cancer_Homo sapiens_hsa05210 | 0.97908364 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.97325616 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.97208288 |
| 59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.96169152 |
| 60 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.93940796 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.93597270 |
| 62 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.93379106 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.92294901 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91478217 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.90684761 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89855220 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88691829 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.88410642 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87160701 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85621850 |
| 71 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85556437 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85336302 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84059575 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.81591457 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.81290432 |
| 76 | Prostate cancer_Homo sapiens_hsa05215 | 0.79618517 |
| 77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79159829 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79065683 |
| 79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79054873 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78868061 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77959531 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.77806393 |
| 83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77363960 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.76328684 |
| 85 | Legionellosis_Homo sapiens_hsa05134 | 0.75707640 |
| 86 | Salmonella infection_Homo sapiens_hsa05132 | 0.75351124 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74717623 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74540624 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73911250 |
| 90 | Axon guidance_Homo sapiens_hsa04360 | 0.71603376 |
| 91 | Influenza A_Homo sapiens_hsa05164 | 0.71472571 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68553333 |
| 93 | Measles_Homo sapiens_hsa05162 | 0.68362857 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.67762647 |
| 95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66629534 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66537097 |
| 97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65998356 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65924315 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65175046 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65126149 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.64163171 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63998599 |
| 103 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63791187 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63257628 |
| 105 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.63142563 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63003279 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63003131 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62839679 |
| 109 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.62690885 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61382677 |
| 111 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59608243 |
| 112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59162933 |
| 113 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57662494 |
| 114 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.57450510 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57078669 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56808625 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56654544 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56604341 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56185970 |
| 120 | * Endocytosis_Homo sapiens_hsa04144 | 0.55036349 |
| 121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54686126 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54344744 |
| 123 | Hepatitis B_Homo sapiens_hsa05161 | 0.54215969 |
| 124 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54124443 |
| 125 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.49786007 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.49586024 |
| 127 | Renin secretion_Homo sapiens_hsa04924 | 0.49403579 |
| 128 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49101820 |
| 129 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48372294 |
| 130 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47950518 |
| 131 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47607925 |
| 132 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46211954 |
| 133 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.45471759 |
| 134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44928566 |
| 135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44228064 |

